1.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-202, NCT00398567
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-203, NCT00445458
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-200, NCT00266877
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-201, NCT00300781
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-102, NCT00146172
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-104, NCT00397046
|
|
7.
|
Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 to 50 Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-105, NCT00708903
|
|
8.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 3144A1-2205, NCT00838539
|